Molecular Publications

1. Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, Kokwaro G, Sasi P, Marsh K, Borrmann S, Mackinnon M, Nzila A.
   Chloroquine resistance before and after its withdrawal in Kenya.
   Malar J. 2009 May 18;8(1):106.
   PMID: 19450282
2. Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P.
   A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria.
   Malar J. 2009 May 4;8:89.
   PMID: 19413906
3. Pearce RJ, Pota H, Evehe MS, Bâ el-H, Mombo-Ngoma G, Malisa AL, Ord R, Inojosa W, Matondo A, Diallo DA, Mbacham W, van den Broek IV, Swarthout TD, Getachew A, Dejene S, Grobusch MP, Njie F, Dunyo S, Kweku M, Owusu-Agyei S, Chandramohan D, Bonnet M, Guthmann JP, Clarke S, Barnes KI, Streat E, Katokele ST, Uusiku P, Agboghoroma CO, Elegba OY, Cissé B, A-Elbasit IE, Giha HA, Kachur SP, Lynch C, Rwakimari JB, Chanda P, Hawela M, Sharp B, Naidoo I, Roper C.
   Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria.
   PLoS Med. 2009 Apr 14;6(4):e1000055. Epub 2009 Apr 14.
   PMID: 19365539
4. Lynch C, Pearce R, Pota H, Cox J, Abeku TA, Rwakimari J, Naidoo I, Tibenderana J, Roper C.
   Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda.
   J Infect Dis. 2008 Jun 1;197(11):1598-604.
   PMID: 18471065
5. Laufer M, Djimdé AA, Plowe CV.
   Monitoring and Deterring Drug-Resistant Malaria in the Era of Combination Therapy
   Am J Trop Med Hyg. 2007 Dec;77(Suppl 6):160-169.
   PMID: 18165489
6. Plowe CV, Roper C, Barnwell JW, Happi CT, Joshi HH, Mbacham W, Meshnick SR, Mugittu K, Naidoo I, Price RN, Shafer RW, Sibley CH, Sutherland CJ, Zimmerman PA, Rosenthal PJ.
   World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria
   Malar J. 2007 Sep 6;6:121.
   PMID: 17822535
7. Mugittu K, Ndejembi M, Malisa A, Lemnge M, Premji Z, Mwita A, Nkya W, Kataraihya J, Abdulla S, Beck HP, Mshinda H.
   Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
   Am J Trop Med Hyg. 2004 Dec;71(6):696-702.
   PMID: 15642957
8. Djimdé AA, Dolo A, Ouattara A, Diakité S, Plowe CV, Doumbo OK.
   Molecular Diagnosis of Resistance to Antimalarial Drugs during Epidemics and in War Zones
   J Infect Dis. 2004 Aug 15;190(4):853-855. Epub 2004 Jul 15.
   PMID: 15272415
9. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Matino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV.
   Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
   J Infect Dis. 2002 Feb 1;185(3):380-388. Epub 2002 Jan 17.
   PMID: 11807721
10. Djimdé A, Doumbo OK, Steketee RW, Plowe CV.
    Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria.
    Lancet. 2001 Sep 15;358(9285):890-891.
    PMID: 11567708